search
Back to results

Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp.

Primary Purpose

Necrotic Pulp, Apical Periodontitis

Status
Not yet recruiting
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
Diclofenac Sodium
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Necrotic Pulp focused on measuring necrosis

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

-

Inclusion criteria:

  • Patients who are free from any physical or mental handicapping condition with no underlying systemic disease.
  • Age between 18-50 years.
  • Males & Females.
  • Mandibular single rooted permanent premolar teeth:

    • Diagnosed clinically with pulp necrosis.
    • Absence of spontaneous pain.
    • Positive pain on percussion denoting apical periodontitis.
    • Slight widening in the periodontal membrane space or with periapical radiolucency not exceeding 2*2 mm radiographically.
  • Patients' acceptance to participate in the trial.
  • Patients who can understand pain scale and can sign the informed consent

Exclusion Criteria:

  • Medically compromised patients
  • Pregnant women.
  • If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively.
  • Patients reporting bruxism or clenching.
  • Teeth that show association with acute periapical abscess and swelling.
  • Greater than grade I mobility or pocket depth greater than 5mm.
  • Non-restorable teeth
  • Teeth with vital pulp.
  • Immature teeth.
  • Radiographic evidence of external or internal root resorption vertical root fracture, perforation, calcification.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Sham Comparator

    Active Comparator

    Arm Label

    calcium hydroxide

    diclofenac sodium

    Arm Description

    calcium hydroxide will be placed as intracanal medication between visits.

    diclofenac sodium will be placed as intracanal medication between visits

    Outcomes

    Primary Outcome Measures

    change in Intensity of postoperative pain
    measured using numerical rating scale (NRS) at 6, 12, 24 and 48- hours post-instrumentation and at 6, 12, 24 and 48 hours post-obturation.

    Secondary Outcome Measures

    Bacterial load reduction
    bacterial counting using agar culture technique after root canal preparation (CFU/ml).

    Full Information

    First Posted
    October 7, 2022
    Last Updated
    November 7, 2022
    Sponsor
    Cairo University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05582421
    Brief Title
    Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp.
    Official Title
    Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp: A Randomized Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    December 2022 (Anticipated)
    Primary Completion Date
    October 2023 (Anticipated)
    Study Completion Date
    August 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Cairo University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    the aim of this study is to compare the effect of using Diclofenac Sodium Versus Calcium Hydroxide as Intracanal medication on intensity of postoperative pain, bacterial load reduction after root canal preparation and periapical matrix metalloproteinase 9 level (MMP-9) post-instrumentation and pre-obturation in teeth with necrotic pulp
    Detailed Description
    To compare the effect of diclofenac sodium versus calcium hydroxide as intra canal medication on: - Primary Outcome Intensity of postoperative pain will be measured using numerical rating scale (NRS) at 6, 12, 24 and 48- hours post-instrumentation and at 6, 12, 24 and 48 hours post-obturation. Secondary Outcome 1 Bacterial load reduction will be determined by bacterial counting using agar culture technique after root canal preparation (CFU/ml). Secondary Outcome 2 Periapical MMP-9 level will be determined post-instrumentation and pre-obturation by ELISA.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Necrotic Pulp, Apical Periodontitis
    Keywords
    necrosis

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Early Phase 1
    Interventional Study Model
    Parallel Assignment
    Model Description
    Trial Design: Randomized Clinical Trial (Parallel Group) Two Arms Allocation Ratio: 1:1 Framework: Superiority
    Masking
    ParticipantInvestigator
    Masking Description
    In this proposed study, both the participant and assessor will be blinded. This is achieved where the outcome assessor will not be informed of the group in which the participant is enrolled for subjective outcomes. The participants will be blinded to the study hypothesis as to which intervention is expected to be better. The patients who already do not know their treatment group will assess the level of their post-operative pain. The laboratory technician at the microbiological department will not know the treatment group of the patients. The treatment groups will remain anonymous at the end of the study during assessment by the statistician.
    Allocation
    Randomized
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    calcium hydroxide
    Arm Type
    Sham Comparator
    Arm Description
    calcium hydroxide will be placed as intracanal medication between visits.
    Arm Title
    diclofenac sodium
    Arm Type
    Active Comparator
    Arm Description
    diclofenac sodium will be placed as intracanal medication between visits
    Intervention Type
    Drug
    Intervention Name(s)
    Diclofenac Sodium
    Intervention Description
    intracanal medication
    Primary Outcome Measure Information:
    Title
    change in Intensity of postoperative pain
    Description
    measured using numerical rating scale (NRS) at 6, 12, 24 and 48- hours post-instrumentation and at 6, 12, 24 and 48 hours post-obturation.
    Time Frame
    6,12.24.48 hours
    Secondary Outcome Measure Information:
    Title
    Bacterial load reduction
    Description
    bacterial counting using agar culture technique after root canal preparation (CFU/ml).
    Time Frame
    7 days
    Other Pre-specified Outcome Measures:
    Title
    Periapical MMP-9 level
    Description
    determined post-instrumentation and pre-obturation by ELISA.
    Time Frame
    7 days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    50 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: - Inclusion criteria: Patients who are free from any physical or mental handicapping condition with no underlying systemic disease. Age between 18-50 years. Males & Females. Mandibular single rooted permanent premolar teeth: Diagnosed clinically with pulp necrosis. Absence of spontaneous pain. Positive pain on percussion denoting apical periodontitis. Slight widening in the periodontal membrane space or with periapical radiolucency not exceeding 2*2 mm radiographically. Patients' acceptance to participate in the trial. Patients who can understand pain scale and can sign the informed consent Exclusion Criteria: Medically compromised patients Pregnant women. If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively. Patients reporting bruxism or clenching. Teeth that show association with acute periapical abscess and swelling. Greater than grade I mobility or pocket depth greater than 5mm. Non-restorable teeth Teeth with vital pulp. Immature teeth. Radiographic evidence of external or internal root resorption vertical root fracture, perforation, calcification.

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp.

    We'll reach out to this number within 24 hrs